InMode to Present at Upcoming Investor Conferences Before the End of 2022

Rhea-AI Summary

InMode Ltd. (Nasdaq: INMD), a global leader in medical technologies, announced participation in three major investor conferences in November and December 2022. The events include:

• Jefferies London Healthcare Conference: Presentation on November 15 at 10:20 a.m. GMT
• Canaccord Genuity MTDF Conference: Presentation on November 17 at 1:00 p.m. ET
• Cantor Medical & Aesthetic Dermatology Conference: Panel on December 8 at 1:45 p.m. ET

Live webcasts will be available for each presentation. For more details, visit InMode's website.

YOKNEAM, Israel, Nov. 1, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will present at the following investor conferences in November:

13^th Annual Jefferies London Healthcare Conference
Presenters: Moshe Mizrahy, Chairman and Chief Executive Officer and Adrian Myrick, VP, Europe & Middle East
Format: In-person presentation and one-on-one meetings
Location: London, U.K.
When: Presentation scheduled for 10:20 a.m. GMT on Tuesday, November 15
A live webcast of the presentation can be accessed here.

2022 Canaccord Genuity MTDF Conference
Presenters: Moshe Mizrahy, Chairman and Chief Executive Officer, Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer
Format: In-person presentation and one-on-one meetings
Location: NYC, U.S.
When: Presentation scheduled for 1:00 pm ET on Thursday, November 17
A live webcast of the presentation can be accessed here.

Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
Presenters: Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer
Format: In-person panel discussion and one-on-one meetings
Location: Miami Beach, U.S.
When: Panel scheduled for 1:45 pm ET on Thursday, December 8

About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:     
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com 
917-607-8654 

View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-investor-conferences-before-the-end-of-2022-301663690.html

SOURCE InMode Ltd.

FAQ

What investor conferences will InMode Ltd. (INMD) participate in November 2022?

InMode Ltd. will participate in the Jefferies London Healthcare Conference on November 15, the Canaccord Genuity MTDF Conference on November 17, and the Cantor Medical & Aesthetic Dermatology Conference on December 8, 2022.

When is InMode's presentation at the Jefferies London Healthcare Conference?

InMode's presentation at the Jefferies London Healthcare Conference is scheduled for November 15, 2022, at 10:20 a.m. GMT.

Where will the Canaccord Genuity MTDF Conference take place for InMode?

The Canaccord Genuity MTDF Conference will be held in New York City, U.S.

What time is InMode's presentation at the Canaccord Genuity MTDF Conference?

InMode's presentation at the Canaccord Genuity MTDF Conference is scheduled for November 17, 2022, at 1:00 p.m. ET.

What is the date and time of InMode's panel at the Cantor Medical Conference?

InMode's panel at the Cantor Medical & Aesthetic Dermatology Conference is scheduled for December 8, 2022, at 1:45 p.m. ET.